ENXTPA • SIGHT • FR0013183985
Generating your data highlights...
N/A USD | # 479 in FR
1.68m shares | 195.73k USD
234.52m
58.16% | 136.4m
GenSight Biologics S.A. (ENXTPA: SIGHT). Last close €0.08 (as of 2026-10-21); 52-week range €0.07 to €0.24. ORTEX data as of 2026-10-19: short interest is 0.63% of free float, 0.4 days to cover and the average cost to borrow is 158.36%.